Picture of Reliance Global logo

EZRA — Reliance Global News Story

0.000.00%
us flag iconLast trade - 00:00
FinancialsSpeculativeMicro CapContrarian

Brief: Reliance Global Group Completes Transformative Investment In Late-Stage Radiopharmaceutical Innovator Innervate Through Ezra’S Biotech Division

May 4 (Reuters) - Reliance Global Group Inc EZRA.O:

RELIANCE GLOBAL GROUP COMPLETES TRANSFORMATIVE INVESTMENT IN LATE-STAGE RADIOPHARMACEUTICAL INNOVATOR INNERVATE THROUGH EZRA’S BIOTECH DIVISION

Source text: ID:nGNX3H9Qmb

Further company coverage: EZRA.O

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Reliance Global

See all news